- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Therapeuticsmd Inc.
Headquarters: Boca Raton, FL, United States of America
Website: http://www.therapeuticsmd.com...
Year Founded: 2008
Status: Public
Industry Sector: HealthTechnology
CEO: Marlan D. Walker
Number Of Employees: 1
Enterprise Value: $12,033,520
PE Ratio: -5.87
Exchange/Ticker 1: NASDAQ:TXMD
Exchange/Ticker 2: N/A
Latest Market Cap: $12,847,600
BioCentury | Feb 10, 2024
Management Tracks
Iambic hires Josephson as CMO
Plus: Cole joins Cadrenal and updates from PrecisioBiotix and 60 Degrees
BioCentury | Dec 6, 2022
Product Development
Dec. 5 Quick Takes: Nkarta reports 70% complete response
Plus: Verve falls on clinical hold and updates from J&J, Affinia, TherapeuticsMD, Biogen and more
BioCentury | Jul 14, 2022
Finance
July 13 Quick Takes: Pliant raises $200M on back of positive data; CytomX restructuring
Plus ContraFect tumbles on exebacase setback, and updates from AgomAb, Xilis, and more
BioCentury | Jun 1, 2022
Finance
May 31 Quick Takes: Ultima emerges with $600M, low-cost sequencing platform
Plus Priority review for Y-mAbs’ Omblastys and updates from Avillion, TG, EW Healthcare, Regeneron, Moderna and more
BioCentury | Nov 16, 2021
Management Tracks
End of an era at Biogen as R&D head Sandrock readies to retire
Plus: Levin-Allerhand joins Flagship, and updates from Alchemab, Agios, Actym, Gilgamesh and more
BioCentury | Oct 19, 2021
Management Tracks
Carl June joins Bioheng’s SAB
Plus: Myriad, Kura, Ideaya, IASO, OncoCyte and more
BioCentury | Aug 13, 2021
Management Tracks
Mehra joins Myovant as chief financial and business officer
Plus: updates from Becton Dickinson, Sesen, Abeona, Quotient, Adverum and more
BioCentury | Jun 10, 2020
Management Tracks
iTeos builds out team with CFO, R&D VP; plus Constellation, SwanBio, Akcea, Amplyx, Antengene and more
BioCentury | Jan 5, 2018
Clinical News
TherapeuticsMD submits NDA for TX-001HR to treat menopause symptoms
Items per page:
1 - 10 of 41